Choice of antipsychotic drugs.
D002090:Butyrophenones / Q000627:therapeutic use; D004357:Drug Synergism; D004361:Drug Tolerance; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D010640:Phenothiazines / Q000627:therapeutic use*; D010879:Piperazines / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use; D011600:Psychopharmacology; D011613:Psychotherapy; D011618:Psychotic Disorders / Q000188:drug therapy*; D013881:Thioridazine / Q000627:therapeutic use; D013888:Thiothixene / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000627:therapeutic use; D014273:Triflupromazine / Q000627:therapeutic use; D014966:Xanthenes / Q000627:therapeutic use
D002090:Butyrophenones; D010640:Phenothiazines; D010879:Piperazines; D010880:Piperidines; D014149:Tranquilizing Agents; D014966:Xanthenes; D013888:Thiothixene; D006220:Haloperidol; D013881:Thioridazine; D014273:Triflupromazine